Ionis Pharmaceuticals IONS recently announced that the FDA has granted orphan drug designation and rare pediatric disease designation to ION582, its investigational antisense medicine for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback